All Stocks/Healthcare/IDXX

IDEXX Laboratories Inc.

IDXXNASDAQ
HealthcareDiagnostics & Research Website
Price ChartPowered by TradingView
Ask about IDXXAI research agent
Alpha Score BreakdownHow it works →

Alpha Score of 32 reflects weak overall profile with weak momentum, poor value, strong quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.

Momentum
30
Poor
Value
0
Poor
Quality
77
Strong
Sentiment
no data
Key StatisticsUpdated Apr 15
P/E Ratio
91.54
Forward P/E
PEG Ratio
EPS (TTM)
6.38
Dividend Yield
Beta
1.68
Revenue (TTM)
Net Margin
24.62%
ROE
69.78%
Debt / Equity
0.53
52W High
$766.68
52W Low
$361.04
Insider ActivitySEC Form 4 filings
Buys (90d)
0
Sells (90d)
23
Net $ (90d)
$-22.5M
Unique insiders
4
DateInsiderRoleTypeSharesValue
Mar 3, 26Hunt NimrataExecutive Vice PresidentSELL1.8K$1.1M
Feb 26, 26Mazelsky Jonathan JayPresident and CEOSELL1.3K$834K
Feb 26, 26Mazelsky Jonathan JayPresident and CEOSELL1.1K$713K
Feb 26, 26Mazelsky Jonathan JayPresident and CEOSELL1.7K$1.1M
Feb 26, 26Mazelsky Jonathan JayPresident and CEOSELL1.2K$765K
Feb 26, 26Mazelsky Jonathan JayPresident and CEOSELL1.1K$727K
Feb 26, 26Mazelsky Jonathan JayPresident and CEOSELL1.5K$976K
Feb 26, 26Mazelsky Jonathan JayPresident and CEOSELL1.3K$882K
Feb 26, 26Mazelsky Jonathan JayPresident and CEOSELL2.9K$1.9M
Feb 26, 26Mazelsky Jonathan JayPresident and CEOSELL3.7K$2.4M
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Citadel
Ken Griffin
73K$49.28MNEW
Point72
Steve Cohen
11K$7.58MNEW
D.E. Shaw
David Shaw
2K$1.11MNEW
Marshall Wace1K$830.1KNEW
Politicians who traded IDXXFrom Senate & House PTRs
PoliticianDateTypeAmount
Byron Donalds
R-FL
2025-09-04purchase$1k – $15k
Jefferson Shreve
R-IN
2025-05-12sale$100k – $250k
April McClain Delaney
D-MD
2025-04-09purchase$1k – $15k
April McClain Delaney
D-MD
2025-04-04purchase$1k – $15k
April McClain Delaney
D-MD
2025-03-14purchase$1k – $15k
Rob Bresnahan
PA
2025-02-25purchase$1k – $15k
Peter Meijer
MI
2021-02-16sale$1k – $15k
Gilbert Cisneros
D-CA
2019-02-26purchase$1k – $15k
About IDEXX Laboratories Inc.

IDEXX Laboratories, Inc. is an American multinational corporation that develops, manufactures, and distributes diagnostic products and services for veterinary and environmental markets. The company specializes in solutions for companion animal health, including in-clinic laboratory analyzers like the Catalyst Dx Chemistry Analyzer and ProCyte Dx Hematology Analyzer, pet-side SNAP tests, diagnostic imaging systems, and veterinary practice management software such as Cornerstone. It also offers water testing products like Colilert for detecting coliforms and E. coli, alongside diagnostics for livestock, poultry, and dairy to monitor diseases in herds and flocks, as well as milk quality. Additionally, IDEXX provides point-of-care and laboratory diagnostics through OPTI Medical Systems for human medicine. These offerings support veterinarians, water utilities, livestock producers, and reference laboratories worldwide, enhancing health monitoring and safety in pet care, agriculture, and public health. Founded in 1983 and headquartered in Westbrook, Maine, IDEXX Laboratories, Inc. plays a key role in advancing diagnostic innovation across these essential sectors.

CEO
Mr. Jonathan J. Mazelsky
Employees
11,000
Quick Facts
ExchangeNASDAQ
SectorHealthcare
IndustryDiagnostics & Research
Market Cap
Avg Volume557.04K
Key Dates

Earnings calendar coming soon. Subscribe to get notified when IDXX reports next.

Get earnings alerts →